Beyond radio-displacement techniques for Identification of CB 1 Ligands: The First Application of a Fluorescence-quenching Assay

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Bruno, Agostino ^a   Lembo, Francesca ^a   Novellino, Ettore ^a   Stornaiuolo, Mariano ^a   Marinelli, Luciana ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; LIGAND; PROTEIN BINDING;

ALLOSTERISM; ANIMAL; CELL LINE; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; GENETICS; HUMAN; IC50; KINETICS; METABOLISM; PROCEDURES; PROTEIN CONFORMATION; RAT; SPECTROFLUOROMETRY;

ALLOSTERIC REGULATION; ANIMALS; CELL LINE; CELL MEMBRANE; DRUG DISCOVERY; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RECEPTOR, CANNABINOID, CB1; SPECTROMETRY, FLUORESCENCE;

EID: 84892856242     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03757     Document Type: Article

References (50)

1. Pacher, P. & Kunos, G. Modulating the endocannabinoid system in human health and disease-successes and failures. Febs J. 280, 1918-1943 (2013
2. Pertwee, R. G. Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities. Philos. Trans. R. Soc. B Biol. Sci. 367, 3353-3363 (2012
3. di Marzo, V. D., Bifulco, M. & Petrocellis, L. D. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 3, 771-784 (2004 (Pubitemid 39242829)
4. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564 (1990
5. Munro, S., Thomas, K. L. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65 (1993 (Pubitemid 23305569)
6. Ryberg, E. et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 152, 1092-1101 (2007 (Pubitemid 350166046)
7. Piomelli, D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4, 873-884 (2003 (Pubitemid 37351427)
8. Freund, T. F., Katona, I. & Piomelli, D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066 (2003 (Pubitemid 36828930)
9. Castillo, P. E., Younts, T. J., Chávez, A. E. & Hashimotodani, Y. Endocannabinoid Signaling and Synaptic Function. Neuron 76, 70-81 (2012
10. Petrocellis, L. D., Cascio, M. G. & Marzo, V. D. The endocannabinoid system: A general view and latest additions. Br. J. Pharmacol. 141, 765-774 (2004 (Pubitemid 38446177)
11. Pertwee, R. G. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci. 76, 1307-1324 (2005
12. Frank, B., Serpell, M. G.,Hughes, J., Matthews, J.N. S. & Kapur, D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Randomised, crossover, double blind study. BMJ 336, 199-201 (2008 (Pubitemid 351212676)
13. Pertwee, R. G. The pharmacology of cannabinoid receptors and their ligands: An overview. Int. J. Obes. 2005 30 Suppl 1, S13-18 (2006
14. Blake, D. R. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 45, 50-52 (2006 (Pubitemid 43033874)
15. Rosengren, R. & Cridge, B. Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manag. Res. 5, 301-313 (2013
16. Price, M. R. et al. Allosteric modulation of the cannabinoid CB1 receptor. Mol. Pharmacol. 68, 1484-1495 (2005 (Pubitemid 41540004)
17. Piscitelli, F. et al. Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB1 Receptor. J. Med. Chem. 55, 5627-5631 (2012
18. Wootten, D., Christopoulos, A. & Sexton, P. M. Emerging paradigms in GPCR allostery: Implications for drug discovery. Nat. Rev. Drug Discov. 12, 630-644 (2013
19. Ross, R. A. Allosterism and cannabinoid CB(1) receptors: The shape of things to come. Trends Pharmacol. Sci. 28, 567-572 (2007 (Pubitemid 350026616)
20. Cawston, E. E. et al. Real-Time characterisation of Cannabinoid Receptor 1 (CB1) allosteric modulators reveals novel mechanism of action.: Allosteric Modulators of CB1. Br. J. Pharmacol. 170, 893-907 (2013
21. Ahn, K. H., Mahmoud, M. M. & Kendall, D. A. Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and Gi Protein-independent ERK1/2 Kinase Activation. J. Biol. Chem. 287, 12070-12082 (2012
22. Ahn, K. H., Mahmoud, M. M., Shim, J-Y. & Kendall, D. A. Distinct Roles of b-Arrestin 1 and b-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1). J. Biol. Chem. 288, 9790-9800 (2013
23. Fay, J. F. & Farrens, D. L. A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569. J. Biol. Chem. 287, 33873-33882 (2012
24. Baillie, G. L. et al. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity. Mol. Pharmacol. 83, 322-338 (2012
25. Devane, W. A., Dysarz, F. A. 3rd., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613 (1988 (Pubitemid 19007296)
26. Roth, S. H. & Williams, P. J. The non-specific membrane binding properties of delta9-Tetrahydrocannabinol and the effects of various solubilizers. J. Pharm. Pharmacol. 31, 224-230 (1979 (Pubitemid 9148920)
27. Harris, L. S., Carchman, R. A. &Martin, B. R. Evidence for the existence of specific cannabinoid binding sites. Life Sci. 22, 1131-1137 (1978
28. Middleton, R. J. & Kellam, B. Fluorophore-Tagged GPCR ligands. Curr. Opin. Chem. Biol. 9, 517-525 (2005 (Pubitemid 41338206)
29. Martín-Couce, L. et al. Chemical Probes for the Recognition of Cannabinoid Receptors in Native Systems. Angew. Chem. Int. Ed. 51, 6896-6899 (2012
30. Daly, C. J. et al. Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-liké receptors in small arteries. Br. J. Pharmacol. 159, 787-796 (2010
31. Sylantyev, S., Jensen, T. P., Ross, R. A. & Rusakov, D. A. Cannabinoid-And lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proc. Natl. Acad. Sci. U. S. A. 110, 5193-5198 (2013
32. Gatley, S. J. et al. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci. 61, PL 191-197 (1997
33. Havunjian, R. H., De Costa, B. R., Rice, K. C. & Skolnick, P. Characterization of benzodiazepine receptors with a fluorescence-quenching ligand. J. Biol. Chem. 265, 22181-22186 (1990 (Pubitemid 120014284)
34. Devane, W. A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949 (1992 (Pubitemid 23026736)
35. MODELLER, Program for Comparative Protein Structure Modelling by Satisfaction of Spatial Restraints, http://salilab.org/modeller
36. Hanson, M. A. et al. Crystal Structure of a Lipid G Protein-Coupled Receptor. Science 335, 851-855 (2012
37. Hurst, D. P., Schmeisser, M.&Reggio, P. H. Endogenous lipid activatedGproteincoupled receptors: Emerging structural features from crystallography and molecular dynamics simulations. Chem. Phys. Lipids 169, 46-56 (2013
38. Hurst, D. P. et al.N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. Mol. Pharmacol. 62, 1274-1287 (2002 (Pubitemid 35403823)
39. McAllister, S. D. et al. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. J. Med. Chem. 46, 5139-5152 (2003 (Pubitemid 37414184)
40. Shim, J-Y., Bertalovitz, A. C. & Kendall, D. A. Probing the Interaction of SR141716A with the CB1 Receptor. J. Biol. Chem. 287, 38741-38754 (2012
41. Wiley, J. L. et al. Novel pyrazole cannabinoids: Insights into CB(1) receptor recognition and activation. J. Pharmacol. Exp. Ther. 296, 1013-1022 (2001 (Pubitemid 32187377)
42. Lan, R. et al. Structure-Activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42, 769-776 (1999 (Pubitemid 29110792)
43. Katritch, V., Cherezov, V. & Stevens, R. C. Structure-Function of the G Protein-Coupled Receptor Superfamily. Annu. Rev. Pharmacol. Toxicol. 53, 531-556 (2013
44. Venkatakrishnan, A. J. et al.Molecular signatures of G-protein-coupled receptors. Nature 494, 185-194 (2013
45. Salo, O. M. H., Lahtela-Kakkonen, M., Gynther, J., Järvinen, T. & Poso, A. Development of a 3D model for the human cannabinoid CB1 receptor. J. Med. Chem. 47, 3048-3057 (2004 (Pubitemid 38702701)
46. Oddi, S. et al. Effects of palmitoylation of Cys415 in helix 8 of the CB1 cannabinoid receptor on membrane localization and signalling: CB1 receptor palmitoylation. Br. J. Pharmacol. 165, 2635-2651 (2012
47. Lopez, R. ClustalWW-WWW Service at the European Bionformatics Institute, http://www.ebi.ac.uk/Tools/msa/clustalw2/, date of acces May 2013
48. Schrödinger, Mestro version 9.1 Schrödinger, LLC, New York 2009
49. Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366-428 (1995
50. Leterrier, C., Bonnard, D., Carrel, D., Rossier, J. & Lenkei, Z. Constitutive endocytic cycle of the CB1 Cannabinoid Receptor. J. Biol. Chem. 279, 36013-36021 (2004)(Pubitemid 39100609)